2018
DOI: 10.1002/ijc.31585
|View full text |Cite
|
Sign up to set email alerts
|

Flubendazole elicits anti‐metastatic effects in triple‐negative breast cancer via STAT3 inhibition

Abstract: Tumor metastasis remains the cause of 90% of cancer-related deaths. Cancer stem cells (CSC) are thought to be responsible for the aggressive and metastatic nature of triple-negative breast cancers (TNBC), and new therapeutic strategies are being devised to target them. Flubendazole (FLU) is a widely used anthelmintic agent that also exhibits anticancer activity in several cancer types. The aim of this study was to characterize the mechanism of action of FLU on breast cancer stem cell (BCSC)-like properties and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
59
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 67 publications
(62 citation statements)
references
References 47 publications
(90 reference statements)
2
59
0
1
Order By: Relevance
“…Previous studies indicate that stimulating EMT and increasing CSCs can promote cancer metastasis and relapse . Cells undergoing EMT are known to acquire stem cell‐like properties.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies indicate that stimulating EMT and increasing CSCs can promote cancer metastasis and relapse . Cells undergoing EMT are known to acquire stem cell‐like properties.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies indicate that stimulating EMT and increasing CSCs can promote cancer metastasis and relapse. 34,[47][48][49][50] Cells undergoing EMT are known to acquire stem cell-like properties. Loss of epithelial marker E-cadherin, increased expression of mesenchymal markers Fibronectin and Vimentin and the EMT regulator Snail, which are important events in EMT.…”
Section: Discussionmentioning
confidence: 99%
“…The canonical activity of STAT3 is mainly dependent on the Janus kinase (JAK) phosphorylation at tyrosine 705 (Y705) [37]. The canonically activated pY705 STAT3 is nuclear targeted and associates with the promoters of early response genes to: promote proliferation, enhance tissue invasion and metastasis (e.g., cyclin D1 and matrix metalloproteinase-2/-9 in breast cancer) [38][39][40][41], activate terminal differentiation and growth arrest, promote evasion of the immune response by suppressing apoptosis [42], promoting angiogenesis, as well as modification of cellular energy metabolism and mitochondrial activity [43,44]. The activation may induce lysosome-mediated apoptosis depending on cell type and conditions or stimulation [45].…”
Section: Canonical Stat3 Signalling and The Warburg Effectmentioning
confidence: 99%
“…These elevated ROS levels can promote tumourigenesis through destabilizing the genome and increasing ROS dependence in signalling pathways [127][128][129]. Despite cancer cells producing the bulk of ATP through the Warburg effect, the mitochondria are still active and contribute to ROS production through OXPHOS [40,41,130,131], and maintenance of Ca 2+ homeostasis [132][133][134][135][136][137]. Myeloid progenitors produce a much higher ROS than leukocytes produced in mammalian hematopoietic systems.…”
Section: Redox Signalling In Cancer: Does Stat3 Maintain the Balance?mentioning
confidence: 99%
“…Ilamycin C suppresses the IL-6/STAT3 pathway in TNBC cells Recent studies showed that activated STAT proteins, especially STAT3, are involved in the progression of many malignant tumors [31]. The suppression of phosphorylated STAT3 (p-STAT3) can induce apoptosis and inhibit metastasis in cancer [32,33]. In TNBC, poor prognosis and chemotherapy resistance are related to the activation of STAT3 [34].…”
Section: Ilamycin C Inhibits Migration and Invasion In Tnbc Cellsmentioning
confidence: 99%